Mark D. Novara - 17 Mar 2025 Form 4 Insider Report for TANDEM DIABETES CARE INC (TNDM)

Role
EVP & CHIEF COMMERCIAL OFFICER
Signature
/s/ Rachel Malina, Attorney-in-Fact for Mark D. Novara
Issuer symbol
TNDM
Transactions as of
17 Mar 2025
Net transactions value
-$52,507
Form type
4
Filing time
19 Mar 2025, 16:12:32 UTC
Previous filing
18 Dec 2024
Next filing
19 May 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TNDM Common Stock Options Exercise $0 +7,415 +38% $0.000000 26,873 17 Mar 2025 Direct
transaction TNDM Common Stock Tax liability $52,507 -2,739 -10% $19.17 24,134 17 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TNDM Restricted Stock Unit Options Exercise $0 -7,415 -13% $0.000000 51,902 17 Mar 2025 Common Stock 7,415 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by Tandem Diabetes Care, Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
F2 Awarded on December 15, 2023 pursuant to the Tandem Diabetes Care, Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
F3 Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
F4 RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 12/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.